| TIMP3 antibodies | |
| This is a review about TIMP3 antibodies, based on 4 published articles using TIMP3 antibodies in western blot, immunohistochemistry, immunoprecipitation, immunocytochemistry, and other immunological technologies. It is aimed to help ExactAntigen visitors find the most suited TIMP3 antibody. Information in this review (with links to publications) can be searched freely. |
SANTA CRUZ BIOTECHNOLOGY search Santa Cruz Biotechnology TIMP3 products
includes other brands or spellings
|
| ic, wb | | Santa Cruz Biotechnology goat polyclonal TIMP-3 antibody was used in western blot and immunocytochemistry to study TIMP3 downregulation in lymphangioleiomyomatosis. |
MILLIPORE search Millipore TIMP3 products
includes other brands or spellings
|
| ih | | Chemicon monoclonal anti-TIMP-3 antibody (Mab 13H-22) was used in paraffin sections from human placenta or eyes and in immunohistochemistry to study the role for the interaction between TIMP-3 and EFEMP1 in macular degenerations. |
| ih | | Chemicon monoclonal TIMP-3 (136-13H4) antibody was used in immunohistochemistry to study its expression in pancreatic cancer. |
| wb | | Chemicon International rabbit anti-human TIMP-3 polyclonal antibody was used in western blot to study the induction a Fas-associated death domain-dependent type II apoptotic pathway by tissue inhibitor of metalloproteinase-3. |
Articles Reviewed |
| 1. Mark Bond et al. Tissue inhibitor of metalloproteinase-3 induces a Fas-associated death domain-dependent type II apoptotic pathway. 2002 |
| 2. Xiaoning Zhe et al. Tissue inhibitor of metalloproteinase-3 downregulation in lymphangioleiomyomatosis: potential consequence of abnormal serum response factor expression. 2003 |
| 3. Lucie E Jones et al. Comprehensive analysis of matrix metalloproteinase and tissue inhibitor expression in pancreatic cancer: increased expression of matrix metalloproteinase-7 predicts poor survival. 2004 |
| 4. Philip A Klenotic et al. Tissue inhibitor of metalloproteinases-3 (TIMP-3) is a binding partner of epithelial growth factor-containing fibulin-like extracellular matrix protein 1 (EFEMP1). Implications for macular degenerations. 2004 |
|